Bristol-Myers Squibb buy Barclays PLC
Start price
21.02.26
/
50%
€50.83
Target price
21.02.27
€63.65
Performance (%)
-3.13%
Price
07:52
€49.50
Summary
This prediction is currently active. With a performance of -3.13%, the BUY prediction for Bristol-Myers Squibb by Barclays_PLC is down slightly. This prediction currently runs until 21.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 1.336% | 1.336% |
| iShares Core DAX® | -1,86 % | -1,62 % |
| iShares Nasdaq 100 | -3,32 % | 3,32 % |
| iShares Nikkei 225® | -2,30 % | 3,44 % |
| iShares S&P 500 | -1,31 % | 2,44 % |
Comments by Barclays_PLC for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $75.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Barclays_PLC for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€48.85
07.10.24
07.10.24
€39.19
07.10.25
07.10.25
-20.99%
08.10.25
08.10.25
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€42.92
22.08.24
22.08.24
€37.80
22.08.25
22.08.25
-4.19%
23.08.25
23.08.25